Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3819252
Max Phase: Preclinical
Molecular Formula: C28H42N6O7
Molecular Weight: 574.68
Molecule Type: Small molecule
Associated Items:
ID: ALA3819252
Max Phase: Preclinical
Molecular Formula: C28H42N6O7
Molecular Weight: 574.68
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)C[C@@H]1NC(=O)[C@H](CNC(=O)[C@@H](N)CC(=O)O)N(Cc2ccccc2)C1=O)C(=O)NC(C)(C)C
Standard InChI: InChI=1S/C28H42N6O7/c1-6-16(2)23(26(40)33-28(3,4)5)32-21(35)13-19-27(41)34(15-17-10-8-7-9-11-17)20(25(39)31-19)14-30-24(38)18(29)12-22(36)37/h7-11,16,18-20,23H,6,12-15,29H2,1-5H3,(H,30,38)(H,31,39)(H,32,35)(H,33,40)(H,36,37)/t16-,18-,19-,20-,23-/m0/s1
Standard InChI Key: QOSIRQNYWJNZFB-WGLQCKHLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 574.68 | Molecular Weight (Monoisotopic): 574.3115 | AlogP: -0.36 | #Rotatable Bonds: 13 |
Polar Surface Area: 200.03 | Molecular Species: ZWITTERION | HBA: 7 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.61 | CX Basic pKa: 8.52 | CX LogP: -3.10 | CX LogD: -3.12 |
Aromatic Rings: 1 | Heavy Atoms: 41 | QED Weighted: 0.18 | Np Likeness Score: -0.23 |
1. Nardone V, Lucarelli AP, Dalle Vedove A, Fanelli R, Tomassetti A, Belvisi L, Civera M, Parisini E.. (2016) Crystal Structure of Human E-Cadherin-EC1EC2 in Complex with a Peptidomimetic Competitive Inhibitor of Cadherin Homophilic Interaction., 59 (10): [PMID:27120112] [10.1021/acs.jmedchem.5b01487] |
Source(1):